Safety and Pharmacokinetic Evaluation of Zika Virus Immune Globulin in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 18 Jul 2019
Price : $35 *
At a glance
- Drugs ZIKV IG (Primary)
- Indications Zika virus infection
- Focus Adverse reactions; First in man
- Sponsors Emergent BioSolutions
- 16 Jul 2019 Status changed from active, no longer recruiting to completed.
- 25 Jan 2019 Planned End Date changed from 1 Feb 2019 to 6 Mar 2019.
- 25 Jan 2019 Planned primary completion date changed from 1 Feb 2019 to 6 Mar 2019.